Document is current
Any future updates will be listed below
-
Authors
Frederiksen, Katrine Hartmund http://orcid.org/0000-0003-0140-2936
Pedersen, Frederik Nørregaard
Vergmann, Anna Stage
Yang, Dawei
Laugesen, Caroline Schmidt
Vestergaard, Jesper Pindbo
Sørensen, Torben Lykke
Cheung, Carol Y
Kawasaki, Ryo
Peto, Tunde
Grauslund, Jakob
-
Funding
Funding for this research was provided by:
Fight for Sight, Denmark - Bagenkop Nielsens Øjen-Fond (Fight for Sight, Denmark - Bagenkop Nielsens Øjen-Fond)
Synoptik-Fonden (Synoptik-Fonden)
Fabrikant Einar Willumsens Mindelegat (Fabrikant Einar Willumsens Mindelegat)
The Research Fund for Region Seeland and Region of Southern Denmark (The Research Fund for Region Seeland and Region of Southern Denmark)
Toyota-Fonden, Denmark (Toyota-Fonden, Denmark)
Grosserer Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts legat (Grosserer Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts legat)
Odense University Hospital – The PhD Fund for operating costs and The OUH Fund for Free Research (Odense University Hospital – The PhD Fund for operating costs and The OUH Fund for Free Research)
Fonden til Lægevidenskabens Fremme (Fonden til Lægevidenskabens Fremme)
- License Information
-
More Information
Article History
Received: 17 March 2023
Accepted: 6 April 2023
First Online: 28 June 2023
Declarations
:
: All participants provided written informed consent. The study was approved by the Regional scientific ethics committee (approval S-20170084), registered at ClinicalTrials.gov (NCT03651011) and followed the tenets of the declaration of Helsinki.
: JG declares participation in the Advisory Board for Bayer, Novartis, Allergan and Roche. KHF, FNP, ASV, DY, CSL, JPV, TLS, CYC, RK and TP declares no conflicts of interest.
